The client-branded adherence program delivered a 2.9 incremental fill increase for the top-tier diabetes brand, representing a 57% lift in adherence (source: Crossix).
Let’s discover how HealthPrize can help you develop a medication adherence program configured to your unique requirements, patient challenges and business needs.

References
- According to 2018 IQVIA data on 15 branded diabetes medications
- Longitudinal effects of medication nonadherence on glycemic control. Egede LE, Gebregziabher M, Echols C, Lynch CP. Ann Pharmacother. 2014 May;48(5):562-70
- Poor medication adherence in type 2 diabetes: recognizing the scope of the problem and its key contributors. Polonsky WH, Henry RR. Patient Prefer Adherence. 2016 Jul 22;10:1299-307.